ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,874,393 | -5.1% | 57,689 | -4.4% | 0.03% | 0.0% |
| Q2 2023 | $4,084,199 | +8.8% | 60,319 | -3.9% | 0.03% | +3.3% |
| Q4 2022 | $3,755,350 | +29.6% | 62,788 | -2.0% | 0.03% | +20.0% |
| Q3 2022 | $2,896,574 | -20.3% | 64,041 | -1.3% | 0.02% | -16.7% |
| Q2 2022 | $3,635,571 | -23.5% | 64,863 | -2.9% | 0.03% | -6.2% |
| Q1 2022 | $4,750,646 | +51.0% | 66,807 | +38.6% | 0.03% | +18.5% |
| Q4 2021 | $3,146,511 | -12.3% | 48,215 | +0.9% | 0.03% | -18.2% |
| Q3 2021 | $3,587,062 | -14.6% | 47,802 | -6.8% | 0.03% | -17.5% |
| Q1 2021 | $4,199,423 | -6.7% | 51,275 | -5.8% | 0.04% | -13.0% |
| Q4 2020 | $4,499,246 | +21.6% | 54,411 | -4.4% | 0.05% | +12.2% |
| Q3 2020 | $3,699,766 | +1.2% | 56,937 | -3.5% | 0.04% | -2.4% |
| Q2 2020 | $3,655,852 | -6.8% | 59,032 | +4.3% | 0.04% | +2.4% |
| Q4 2019 | $3,920,543 | – | 56,598 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |